Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.
作者信息
Cohen Jeffrey I
机构信息
Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
J Infect Dis. 2017 Mar 15;215(6):844-846. doi: 10.1093/infdis/jix006.
Abstract
摘要
相似文献
1
Vaccination to Reduce Reactivation of Herpes Simplex Virus Type 2.接种疫苗以减少2型单纯疱疹病毒的再激活
J Infect Dis. 2017 Mar 15;215(6):844-846. doi: 10.1093/infdis/jix006.
2
Safety and immunogenicity of a glycoprotein D genital herpes vaccine in healthy girls 10-17 years of age: results from a randomised, controlled, double-blind trial.10-17 岁健康女童中糖蛋白 D 型生殖器疱疹疫苗的安全性和免疫原性：一项随机、对照、双盲试验的结果。
Vaccine. 2013 Dec 9;31(51):6136-43. doi: 10.1016/j.vaccine.2013.06.081. Epub 2013 Jul 9.
3
[Inactivated herpes simplex virus types 1 and 2 divaccine as an agent for effective immunoprophylaxis of recurrent genital herpes].
Vopr Virusol. 2010 Jan-Feb;55(1):35-40.
4
Genital herpes vaccine shows limited promise.
JAMA. 2000 Oct 18;284(15):1913-4.
5
Herpes simplex virus (HSV) type 2 glycoprotein D subunit vaccines and protection against genital HSV-1 or HSV-2 disease in guinea pigs.2型单纯疱疹病毒糖蛋白D亚单位疫苗与豚鼠生殖器1型或2型单纯疱疹病毒疾病的预防
J Infect Dis. 2003 Feb 15;187(4):542-9. doi: 10.1086/374002. Epub 2003 Feb 7.
6
Intramuscular vaccination of guinea pigs with the live-attenuated human herpes simplex vaccine VC2 stimulates a transcriptional profile of vaginal Th17 and regulatory Tr1 responses.豚鼠经肌肉内接种活减毒人单纯疱疹病毒 VC2 疫苗可刺激阴道 Th17 和调节性 Tr1 应答的转录谱。
Vaccine. 2018 May 11;36(20):2842-2849. doi: 10.1016/j.vaccine.2018.03.075. Epub 2018 Apr 11.
7
Immunology. Painful failure of promising genital herpes vaccine.免疫学。有前景的生殖器疱疹疫苗遭遇令人痛苦的失败。
Science. 2010 Oct 15;330(6002):304. doi: 10.1126/science.330.6002.304.
8
Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.2型单纯疱疹病毒亚单位疫苗诱导的有限抗体依赖性细胞毒性抗体反应。
J Infect Dis. 2000 Jan;181(1):335-9. doi: 10.1086/315208.
9
Protection from genital herpes disease, seroconversion and latent infection in a non-lethal murine genital infection model by immunization with an HSV-2 replication-defective mutant virus.通过用HSV-2复制缺陷型突变病毒免疫，在非致死性小鼠生殖器感染模型中预防生殖器疱疹疾病、血清转化和潜伏感染。
Virology. 2016 Jan 15;488:61-7. doi: 10.1016/j.virol.2015.10.033. Epub 2015 Nov 21.
引用本文的文献
1
A review of HSV pathogenesis, vaccine development, and advanced applications.单纯疱疹病毒发病机制、疫苗研发及应用进展综述
Mol Biomed. 2024 Aug 29;5(1):35. doi: 10.1186/s43556-024-00199-7.
2
Triterpenes and Phenolic Compounds from with Antiviral Activity against Herpes Simplex Virus Type-2.具有抗单纯疱疹病毒2型活性的[植物名称未给出]中的三萜类和酚类化合物
Plants (Basel). 2022 Mar 13;11(6):764. doi: 10.3390/plants11060764.
3
A Novel High-Intensity Focused Ultrasound-Treated Herpes Simplex Virus 2 Vaccine Induces Long-Term Protective Immunity against Lethal Challenge in Mice.新型高强度聚焦超声处理单纯疱疹病毒 2 疫苗可诱导小鼠长期的保护性免疫，抵抗致死性攻击。
mSphere. 2020 Dec 23;5(6):e00859-20. doi: 10.1128/mSphere.00859-20.
4
Alphaherpesvirus Vaccines.甲型疱疹病毒疫苗
Curr Issues Mol Biol. 2021;41:469-508. doi: 10.21775/cimb.041.469. Epub 2020 Sep 23.
5
Successful application of prime and pull strategy for a therapeutic HSV vaccine.治疗性单纯疱疹病毒疫苗的初免和激发策略的成功应用。
NPJ Vaccines. 2019 Aug 1;4:33. doi: 10.1038/s41541-019-0129-1. eCollection 2019.
6
Antibody response to feline herpesvirus-1 vaccination in healthy adult cats.健康成年猫中针对猫疱疹病毒-1 疫苗的抗体反应。
J Feline Med Surg. 2020 Apr;22(4):329-338. doi: 10.1177/1098612X19845702. Epub 2019 May 13.
7
Herpes Simplex Virus Shedding Rate: Surrogate Outcome for Genital Herpes Recurrence Frequency and Lesion Rates, and Phase 2 Clinical Trials End Point for Evaluating Efficacy of Antivirals.单纯疱疹病毒脱落率：生殖器疱疹复发频率和病变率的替代结局，以及评估抗病毒药物疗效的 2 期临床试验终点。
J Infect Dis. 2018 Oct 20;218(11):1691-1699. doi: 10.1093/infdis/jiy372.
8
A trivalent subunit antigen glycoprotein vaccine as immunotherapy for genital herpes in the guinea pig genital infection model.三价亚单位抗原糖蛋白疫苗作为免疫疗法治疗豚鼠生殖器感染模型中的生殖器疱疹。
Hum Vaccin Immunother. 2017 Dec 2;13(12):2785-2793. doi: 10.1080/21645515.2017.1323604. Epub 2017 May 8.
本文引用的文献
1
Therapeutic Vaccine for Genital Herpes Simplex Virus-2 Infection: Findings From a Randomized Trial.用于单纯疱疹病毒2型生殖器感染的治疗性疫苗：一项随机试验的结果
J Infect Dis. 2017 Mar 15;215(6):856-864. doi: 10.1093/infdis/jix004.
2
Effect of Pritelivir Compared With Valacyclovir on Genital HSV-2 Shedding in Patients With Frequent Recurrences: A Randomized Clinical Trial.普瑞巴林与伐昔洛韦对生殖器疱疹病毒 2 频繁复发患者生殖器排毒的影响：一项随机临床试验。
JAMA. 2016 Dec 20;316(23):2495-2503. doi: 10.1001/jama.2016.18189.
3
Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.带状疱疹亚单位疫苗在 70 岁及以上成人中的疗效。
N Engl J Med. 2016 Sep 15;375(11):1019-32. doi: 10.1056/NEJMoa1603800.
4
An escalating dose study to assess the safety, tolerability and immunogenicity of a Herpes Simplex Virus DNA vaccine, COR-1.一项评估单纯疱疹病毒DNA疫苗COR-1安全性、耐受性和免疫原性的递增剂量研究。
Hum Vaccin Immunother. 2016 Dec;12(12):3079-3088. doi: 10.1080/21645515.2016.1221872.
5
Current Concepts for Genital Herpes Simplex Virus Infection: Diagnostics and Pathogenesis of Genital Tract Shedding.生殖器单纯疱疹病毒感染的当前概念：生殖道排毒的诊断与发病机制
Clin Microbiol Rev. 2016 Jan;29(1):149-61. doi: 10.1128/CMR.00043-15.
6
Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on "Next Generation Herpes Simplex Virus Vaccines".美国国立过敏与传染病研究所（NIAID）关于“下一代单纯疱疹病毒疫苗”研讨会的总结与建议
Vaccine. 2014 Mar 20;32(14):1561-2. doi: 10.1016/j.vaccine.2014.01.052. Epub 2014 Jan 28.
7
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection.CD8αα+ 皮肤固有 T 细胞在人类疱疹病毒感染中的免疫监视作用。
Nature. 2013 May 23;497(7450):494-7. doi: 10.1038/nature12110. Epub 2013 May 8.
8
The challenge of developing a herpes simplex virus 2 vaccine.开发单纯疱疹病毒 2 疫苗面临的挑战。
Expert Rev Vaccines. 2012 Dec;11(12):1429-40. doi: 10.1586/erv.12.129.
9
ASP2151 for the treatment of genital herpes: a randomized, double-blind, placebo- and valacyclovir-controlled, dose-finding study.ASP2151 治疗生殖器疱疹的随机、双盲、安慰剂和伐昔洛韦对照剂量研究。
J Infect Dis. 2012 Apr 1;205(7):1100-10. doi: 10.1093/infdis/jis019. Epub 2012 Feb 20.
10
Standard-dose and high-dose daily antiviral therapy for short episodes of genital HSV-2 reactivation: three randomised, open-label, cross-over trials.标准剂量和高剂量每日抗病毒疗法治疗生殖器单纯疱疹病毒 2 型短期再激活：三项随机、开放标签、交叉试验。
Lancet. 2012 Feb 18;379(9816):641-7. doi: 10.1016/S0140-6736(11)61750-9. Epub 2012 Jan 4.
Zotero 插件